Loading
Life sciences · Journal article
Radiology Artificial Intelligence · October 28, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Purpose To develop and evaluate an interpretable CT spatial phenotype associated with extrapancreatic perineural invasion (EPNI) in resected pancreatic ductal adenocarcinoma. Materials and Methods This multicenter study included training, internal testing, neoadjuvant testing, retrospective external testing, prospective external testing, and The Cancer Imaging Archive (TCIA) sets. The Preoperative Risk of Perineural High-risk Extension in Tumors (PROPHET) model and threshold were locked before testing. Performance was assessed with area under the receiver operating characteristic curve (AUC) and threshold metrics. Six radiologists compared unaided and assisted readings. A stratified Cox model related PROPHET risk to survival, adjusting for age, sex, tumor size, carbohydrate antigen 19-9, nodal category, and differentiation. Results Among 1854 patients (median age, 63 years; 1131 male), AUCs were 0.92 (95% CI, 0.86–0.96) in prospective external testing, 0.85 (95% CI, 0.75–0.93) in retrospective external testing, 0.90 (95% CI, 0.83–0.95) after neoadjuvant therapy, 0.99 (95% CI, 0.98–> 0.99) in internal testing, and 0.80 (95% CI, 0.68–0.93) in TCIA. TCIA sensitivity and specificity were 24/30 (80%) and 2/19 (11%). Assistance increased mean sensitivity to 93% from 82% and reduced reading time to 3.02 from 3.64 minutes per patient (both Holm-adjusted P <.001). Higher PROPHET risk was associated with shorter survival (adjusted hazard ratio, 1.95; 95% CI, 1.53–2.47; nominal P <.001). Conclusion PROPHET provides a CT-visible tumor-vessel spatial phenotype associated with pathologically confirmed EPNI. © The Author(s) 2026. Published by the Radiological Society of North America under a CC BY 4.0 license.